Catalyst Financial Partners’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$539K Buy
+2,797
New +$301K 0.05% 225

Other funds holding MRNA

Catalyst Financial Partners's MRNA Position: Q3 2026 in Review

Catalyst Financial Partners opened a new position in Moderna (MRNA) in Q3 2026: 2,797 shares worth $539K. The stake represents 0.05% of the portfolio and ranks #225 among its holdings.

1,028 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • Catalyst Financial Partners held 2,797 shares of Moderna worth $539K as of Q3 2026.
  • Moderna was a new Catalyst Financial Partners position in Q3 2026.
  • Moderna made up 0.05% of Catalyst Financial Partners's portfolio in Q3 2026, its #225 holding.
  • 1,028 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Catalyst Financial Partners's 13F filing for Q3 2026, filed 6 Nov 2026.